- Home
- ANVS vs LEE Comparison
ANVS vs LEE Comparison
Compare ANVS & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | LEE |
|---|---|---|
| Founded | 2008 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 209.0M |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ANVS | LEE |
|---|---|---|
| Price | $1.94 | $11.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 68.5K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.39 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $543,955,000.00 |
| Revenue This Year | N/A | $5.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.54 | $3.34 |
| 52 Week High | $5.50 | $11.88 |
Technical Indicators
Market Signals| Indicator | ANVS | LEE |
|---|---|---|
| Relative Strength Index (RSI) | 46.81 | 68.60 |
| Support Level | $1.79 | $7.95 |
| Resistance Level | $2.38 | N/A |
| Average True Range (ATR) | 0.16 | 0.91 |
| MACD | -0.02 | 0.18 |
| Stochastic Oscillator | 32.28 | 79.58 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.